Güttler F, Azen C, Guldberg P, Romstad A, Hanley W B, Levy H L, Matalon R, Rouse B M, Trefz F, de la Cruz F, Koch R
John F. Kennedy Institute, Glostrup, Denmark.
Pediatrics. 1999 Aug;104(2 Pt 1):258-62. doi: 10.1542/peds.104.2.258.
To examine the relationship of phenylalanine hydroxylase (PAH) genotypes to biochemical phenotype and cognitive development in maternal phenylketonuria (PKU).
PAH gene mutations were examined in 222 hyperphenylalaninemic females enrolled in the Maternal PKU Collaborative Study (MPKUCS). A total of 84 different mutations were detected, and complete genotype was obtained in 199 individuals. Based on previous knowledge about mutation-phenotype associations, 78 of the mutations could be assigned to one of four classes of severity (severe PKU, moderate PKU, mild PKU, and mild hyperphenylalaninemia [MHP]). Then, 189 MPKUCS subjects were grouped according to the various combinations of mutation classifications. The sample sizes were large enough for statistical testing in four groups with at least one mutation that completely abolishes enzyme activity. These patients are considered functionally hemizygous.
The biochemical phenotype predicted from the genotype in functionally hemizygous patients was related significantly to the assigned phenylalanine level. Cognitive performance (IQ) was also significantly related to genotype. The IQ of PAH-deficient mothers with a severe PKU mutation in combination with a MHP mutation or a mild PKU mutation was 99 and 96, respectively, whereas the IQ of PKU mothers with two severe PKU mutations or with one severe and one moderate PKU mutation was 83 and 84, respectively. Of the patients with PKU, 92% had been treated during childhood. Those who were untreated or treated late had lower than average IQ scores for their group of mutation combinations. Females with moderate or mild PKU who were treated early and treated for >6 years showed IQ scores 10 points above average for their group.
The reproductive outcome in maternal phenylketonuria is dependent on prenatal metabolic control and postnatal environmental circumstances. Both factors depend on the intellectual resources of the mother with PKU. The significant relationship among genotype, biochemical phenotype, and cognitive performance observed in the present study is of importance for the development of an optimal strategy for future treatment of females with PKU who plan pregnancy.
研究苯丙酮尿症(PKU)母亲中苯丙氨酸羟化酶(PAH)基因型与生化表型及认知发育之间的关系。
在参与母体苯丙酮尿症协作研究(MPKUCS)的222名高苯丙氨酸血症女性中检测PAH基因突变。共检测到84种不同突变,199名个体获得了完整基因型。根据先前关于突变-表型关联的知识,其中78种突变可归为四类严重程度之一(重度PKU、中度PKU、轻度PKU和轻度高苯丙氨酸血症[MHP])。然后,根据突变分类的不同组合对189名MPKUCS受试者进行分组。样本量足够大,可对四组中至少有一个完全消除酶活性的突变进行统计学检验。这些患者被视为功能上的半合子。
功能上半合子患者基因型预测的生化表型与指定的苯丙氨酸水平显著相关。认知表现(智商)也与基因型显著相关。携带重度PKU突变并伴有MHP突变或轻度PKU突变的PAH缺陷母亲的智商分别为99和96,而携带两个重度PKU突变或一个重度和一个中度PKU突变的PKU母亲的智商分别为83和84。PKU患者中,92%在儿童期接受过治疗。未接受治疗或治疗较晚的患者,其突变组合组的智商得分低于平均水平。早期接受治疗且治疗时间超过6年的中度或轻度PKU女性,其智商得分比该组平均水平高10分。
母体苯丙酮尿症患者生育结局取决于产前代谢控制和产后环境情况。这两个因素都取决于PKU母亲的智力资源。本研究中观察到的基因型、生化表型和认知表现之间的显著关系,对于制定未来计划怀孕的PKU女性的最佳治疗策略具有重要意义。